[1]于京虎.复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病患者认知功能及SOD水平的影响[J].医学信息,2023,36(03):148-151.[doi:10.3969/j.issn.1006-1959.2023.03.031]
　YU Jing-hu.Effect of Compound Porcine Cerebroside and Ganglioside Combined with Donepezil on Cognitive Function and SOD Level in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(03):148-151.[doi:10.3969/j.issn.1006-1959.2023.03.031]
点击复制

复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病患者认知功能及SOD水平的影响()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年03期
页码:
148-151
栏目:
药物与临床
出版日期:
2023-02-01

文章信息/Info

Title:
Effect of Compound Porcine Cerebroside and Ganglioside Combined with Donepezil on Cognitive Function and SOD Level in Patients with Alzheimer’s Disease
文章编号:
1006-1959（2023）03-0148-04
作者:
于京虎
（佳木斯市精神病医院精神七科，黑龙江 佳木斯 154002）
Author(s):
YU Jing-hu
(The Seventh Department of Psychiatry,Jiamusi Psychiatric Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
阿尔茨海默病; 复方脑肽节苷脂; 多奈哌齐; 认知功能; 自理能力
Keywords:
Alzheimer’s disease; Compound Porcine Cerebroside and Ganglioside; Donepezil; Cognitive function; Self-care ability
分类号:
R749.1+6
DOI:
10.3969/j.issn.1006-1959.2023.03.031
文献标志码:
A
摘要:
目的 研究复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病（AD）患者认知功能及超氧化物歧化酶（SOD）水平的影响。方法 选取佳木斯市精神病医院2020年12月-2021年12月收治的78例AD患者，按照随机数字表法分为对照组与观察组，各39例。对照组接受多奈哌齐治疗，观察组采用复方脑肽节苷脂联合多奈哌齐治疗，比较两组认知功能[蒙特利尔认知评估量表（MoCA）、简易精神状态检查量表（MMSE）评分]、病情改善情况[阿尔茨海默病评定量表（ADAS）、长谷川痴呆量表（HDS）评分]、血清生化指标[β-淀粉样蛋白（Aβ）、超氧化物歧化酶（SOD）、丙二醛（MDA）]、生活自理能力[阿尔茨海默病协作研究日常能力量表（ADCS-ADL）评分]及生活质量[老年性痴呆生活质量量表（QOL-AD）评分]。结果 两组治疗后MoCA、MMSE评分均有升高，且观察组高于对照组（P＜0.05）；观察组治疗后ADAS评分低于对照组，HDS评分高于对照组（P＜0.05）；观察组治疗后Aβ、MDA水平低于对照组，SOD水平高于对照组（P＜0.05）；两组治疗后ADCS-ADL、QOL-AD评分均有上升，且观察组高于对照组（P＜0.05）。结论 复方脑肽节苷脂联合多奈哌齐可提高AD患者认知功能，控制病情进展，缓解氧化应激，有利于自理能力与生活质量的改善。
Abstract:
Objective To study the effect of compound porcine cerebroside and ganglioside combined with donepezil on cognitive function and superoxide dismutase (SOD) level in patients with Alzheimer’s disease (AD).Methods A total of 78 AD patients admitted to Jiamusi Psychiatry Hospital from December 2020 to December 2021 were selected and divided into control group and observation group according to random number table method, with 39 cases in each group. The control group was treated with donepezil, and the observation group was treated with compound porcine cerebroside and ganglioside combined with donepezil. The cognitive function [Montreal Cognitive Assessment Scale (MoCA), Mini Mental State Examination Scale (MMSE) score], disease improvement [Alzheimer’s Disease Assessment Scale (ADAS), Hasegawa Dementia Scale (HDS) score], serum biochemical indicators [β-amyloid (Aβ), superoxide dismutase (SOD), malondialdehyde (MDA)], self-care ability [Alzheimer’s Disease Collaborative Study Daily Ability Scale (ADCS-ADL) score], and quality of life [Quality of Life in Alzheimer’s Disease Scale (QOL-AD) score] were compared between the two groups.Results After treatment, the scores of MoCA and MMSE in the two groups increased, and those in the observation group were higher than the control group (P<0.05). After treatment, the ADAS score of the observation group was lower than that of the control group, and the HDS score was higher than that of the control group (P<0.05). After treatment, the levels of Aβ and MDA in the observation group were lower than those in the control group, and the level of SOD was higher than that in the control group (P<0.05). After treatment, the ADCS-ADL and QOL-AD scores of the two groups increased, and those in the observation group were higher than the control group (P<0.05).Conclusion Compound porcine cerebroside and ganglioside combined with donepezil can improve the cognitive function of AD patients, control the progression of the disease, alleviate oxidative stress, and improve self-care ability and quality of life.

参考文献/References:

[1]张慧敏,赵彥玲,华元元,等.喹硫平联合多奈哌齐对阿尔茨海默病患者认知功能及单胺类递质水平的影响[J].国际精神病学杂志,2020,47(2):316-318,332.[2]李瑞天,赵园园,蔡灵钰,等.盐酸多奈哌齐对阿尔茨海默病患者认知功能及氧化应激水平的影响[J].中国医药,2020,15(3):382-385.[3]宋宇,方堃,杨文君,等.不同剂量多奈哌齐对阿尔茨海默病患者认知功能及血清IGF-1水平的影响[J].检验医学与临床,2020,17(6):761-764.[4]Pascoal TA,Benedet AL,Ashton NJ,et al.Microglial activation and tau propagate jointly across Braak stages[J].Nature Medicine,2021,27(11):2048-2049.[5]张福华,范文娟,华新宇,等.复方脑肽节苷脂可改善宫内缺氧新生模型小鼠脑损伤并促进突触再生[J].中国组织工程研究,2020,24(11):1689-1694.[6]田金洲,解恒革,王鲁宁,等.中国阿尔茨海默病痴呆诊疗指南(2020年版)[J].中华老年医学杂志,2021,40(3):269-283.[7]高章代,贺毅,戚莉君,等.盐酸多奈哌齐对AD患者Cys C、Hcy水平的影响及其与认知功能的关系[J].检验医学与临床,2019,16(24):3680-3683.[8]林荫,罗海东,张云志,等.盐酸多奈哌齐联合氯氮平治疗阿尔茨海默病伴精神行为障碍的疗效观察[J].中国医院药学杂志,2019,39(14):1476-1479.[9]沈建根,林勇,费玉娥,等.多奈哌齐联合喹硫平治疗阿尔茨海默病精神行为症状远期疗效[J].医药导报,2018,37(10):1206-1209.[10]丛燕楠,孙海荣,张金彪,等.丙戊酸镁联合多奈哌齐治疗阿尔茨海默病的效果及对患者尿阿尔茨海默病相关神经丝蛋白与血浆脂蛋白相关磷脂酶A2水平的影响[J].中国医药,2018,13(7):1025-1029.[11]孙国兵,付斌,谭倩,等.丁苯酞联合多奈哌齐对阿尔茨海默病患者认知功能及脑血管储备功能的影响[J].疑难病杂志,2018,17(8):781-785,865.[12]时婧,左瑞菊,王占强.丁苯酞联合多奈哌齐对阿尔茨海默病患者认知功能及脑血管储备功能的影响[J].临床误诊误治,2018,31(7):98-102.[13]方玲娟,严依军.盐酸多奈哌齐治疗阿尔茨海默病的临床疗效分析[J].中国神经免疫学和神经病学杂志,2018,25(4):271-273.[14]Nobili A,Latagliata EC,Viscomi MT,et al.Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease[J].Nature Communications,2017,8(1):362-381.[15]陈赟,何志聪,李战辉,等.多奈哌齐治疗阿尔茨海默病的疗效、安全性及其对患者血清炎症因子的影响[J].医学临床研究,2018,35(1):195-197.[16]赵师德,鲜利群,陈峰.多奈哌齐治疗阿尔茨海默病的临床疗效及其对β淀粉样蛋白、炎性因子的影响研究[J].实用心脑肺血管病杂志,2018,26(1):42-45.[17]高聚,姜华,宛丰,等.高压氧联合多奈哌齐治疗阿尔茨海默病的疗效及对血清内皮素-1的影响[J].神经损伤与功能重建,2017,12(3):269-271.[18]余雪君,刘欣艳,李英梅,等.多奈哌齐对阿尔茨海默病患者外周血Aβ1-42和Tau蛋白浓度的影响[J].老年医学与保健,2017,23(2):102-104.[19]王丽华,杨慧,王国辉,等.多奈哌齐治疗阿尔茨海默病的远期疗效和安全性[J].医学综述,2017,23(2):356-359.[20]李兴明,刘娟娟,陈俊斌,等.复方脑肽节苷脂注射液对急性脑梗死的临床疗效及对患者Lp-PLA2 hs-CRP NSE水平的影响[J].河北医学,2020,26(3):393-397.[21]王琳,杜广清,齐琳.复方脑肽节苷脂联合多奈哌齐治疗阿尔茨海默症的临床研究[J].现代药物与临床,2018,33(8):1907-1910.[22]Miao Y,Wang R,Wu H,et al.CPCGI confers neuroprotection by enhancing blood circulation and neurological function in cerebral ischemia/reperfusion rats[J].Mol Med Rep,2019,20(3):2365-2372.[23]Wang J,Gu BJ,Masters CL,et al.A systemic view of Alzheimer disease - insights from amyloid-β metabolism beyond the brain.[J].Nature Reviews Neurology,2017,13(11):703.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
　LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Journal of Medical Information,2018,31(03):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]赖 超,成官迅.rs-fMRI、DTI及1H-MRS在阿尔茨海默病中的应用进展[J].医学信息,2018,31(13):41.[doi:10.3969/j.issn.1006-1959.2018.13.013]
　LAI Chao,CHENG Guan-xun.Application of rs-fMRI、DTI and 1H-MRS in Alzheimer’s Disease[J].Journal of Medical Information,2018,31(03):41.[doi:10.3969/j.issn.1006-1959.2018.13.013]
[3]唐娟娟,高春岭,秦凤琴.蒙特利尔认知评估量表在成都市郫都区老年性痴呆筛查中的应用分析[J].医学信息,2018,31(19):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
　TANG Juan-juan,GAO Chun-ling,QIN Feng-qin.Application Analysis of Montreal Cognitive Assessment Scale in Screening for Alzheimer’s Disease in Pidu District,Chengdu[J].Journal of Medical Information,2018,31(03):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
[4]张 辉,张 颖.多奈哌齐联合司来吉兰对阿尔茨海默病患者认知功能及不良反应的影响[J].医学信息,2022,35(13):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
　ZHANG Hui,ZHANG Ying.Effect of Donepezil Combined with Selegilan on Cognitive Function and Adverse Reactions in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2022,35(03):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
[5]杨联勇,沈金娥.阿尔茨海默病新药的临床实验研究[J].医学信息,2020,33(02):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
　YANG Lian-yong,SHEN Jin-e.Clinical Experimental Study of New Drugs for Alzheimer’s Disease[J].Journal of Medical Information,2020,33(03):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
[6]康晨瑶,刘 洲,周海红.NLRP3炎症小体在AD发病机制中的作用[J].医学信息,2021,34(12):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
　KANG Chen-yao,LIU Zhou,ZHOU Hai-hong.The Role of NLRP3 Inflammasome in the Pathogenesis of AD[J].Journal of Medical Information,2021,34(03):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
[7]韦春英,莫颖敏.阿尔茨海默病早期诊断的脑脊液和血液生物标志物研究[J].医学信息,2021,34(14):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
　WEI Chun-ying,MO Ying-min.Study on Cerebrospinal Fluid and Blood Biomarkers for Early Diagnosis of Alzheimer’s Disease[J].Journal of Medical Information,2021,34(03):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
[8]张 瑞,延沁儒.丹酚酸B调节Bax/Bcl-2的表达对阿尔茨海默病小鼠认知功能的影响及机制[J].医学信息,2021,34(17):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
　ZHANG Rui,YAN Qin-ru.Effects of Salvianolic Acid B on the Cognitive Function of Alzheimer’s Disease Mice and its Mechanism Regulating the Expression of Bax/Bcl-2[J].Journal of Medical Information,2021,34(03):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
[9]徐 静.综合康复护理对阿尔兹海默病患者认知功能及生活能力的影响[J].医学信息,2023,36(04):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]
　XU Jing.Effect of Comprehensive Rehabilitation Nursing on Cognitive Function and Living Ability of Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(03):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]
[10]陈浩宇,张 淼,张德锦,等.基于数据挖掘技术分析穴位按摩治疗阿尔茨海默病的选穴规律[J].医学信息,2023,36(08):7.[doi:10.3969/j.issn.1006-1959.2023.08.002]
　CHEN Hao-yu,ZHANG Miao,ZHANG De-jin,et al.Analysis of Acupoint Selection Rules in Treating Alzheimer’s Disease with Acupoint Massage Based on Data Mining[J].Journal of Medical Information,2023,36(03):7.[doi:10.3969/j.issn.1006-1959.2023.08.002]

更新日期/Last Update: 1900-01-01